MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: A randomized, controlled trialFredrick M. Wigley, David Fiorentino, Murray Baron et al.|Arthritis & Rheumatism|2009Cited by 110